TSPO and myocardial infarction: In the current study, the putative cardioprotective role of 4′-ClDzp treatment, a negatively regulating ligand of TSPO modulation, was investigated, in the context of ISO-induced myocardial damage in rats, a model of chronic catecholamine activation and consecutive MI.